Detalles de la búsqueda
1.
Temporal trends and transmission dynamics of pre-treatment HIV-1 drug resistance within and between risk groups in Kenya, 1986-2020.
J Antimicrob Chemother
; 79(2): 287-296, 2024 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-38091580
2.
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in children and adolescents in Africa: A randomised, placebo-controlled, multicentre Phase II clinical trial.
PLoS Med
; 19(1): e1003865, 2022 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35015777
3.
Feasibility of conducting HIV prevention trials among key populations in Nairobi, Kenya.
BMC Public Health
; 22(1): 2385, 2022 12 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-36536335
4.
Safety and immunogenicity of 2-dose heterologous Ad26.ZEBOV, MVA-BN-Filo Ebola vaccination in healthy and HIV-infected adults: A randomised, placebo-controlled Phase II clinical trial in Africa.
PLoS Med
; 18(10): e1003813, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34714820
5.
Safety and Immunogenicity of a 2-Dose Heterologous Vaccine Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Nairobi, Kenya.
J Infect Dis
; 220(1): 57-67, 2019 06 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-30796816
6.
Control of the HIV-1 Load Varies by Viral Subtype in a Large Cohort of African Adults With Incident HIV-1 Infection.
J Infect Dis
; 220(3): 432-441, 2019 07 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-30938435
7.
Utility of Different Adherence Measures for PrEP: Patterns and Incremental Value.
AIDS Behav
; 22(4): 1165-1173, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29090394
8.
Assessment of the Safety and Immunogenicity of 2 Novel Vaccine Platforms for HIV-1 Prevention: A Randomized Trial.
Ann Intern Med
; 164(5): 313-22, 2016 Mar 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26833336
9.
Understanding Adherence to Daily and Intermittent Regimens of Oral HIV Pre-exposure Prophylaxis Among Men Who Have Sex with Men in Kenya.
AIDS Behav
; 19(5): 794-801, 2015 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-25432877
10.
Early antiretroviral therapy and its impact on natural killer cell dynamics in HIV-1 infected men who have sex with men: a cross-sectional pilot study evaluating the impact of early ART initiation on NK cell perturbation in HIV infection.
Microbiol Spectr
; 12(4): e0357023, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38364104
11.
High acceptability of HIV pre-exposure prophylaxis but challenges in adherence and use: qualitative insights from a phase I trial of intermittent and daily PrEP in at-risk populations in Kenya.
AIDS Behav
; 17(6): 2162-72, 2013 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-23080358
12.
Hepatitis B status and associated factors among participants screened for simulated HIV vaccine efficacy trials in Kenya and Uganda.
PLoS One
; 18(7): e0288604, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37459311
13.
Developing standards of care for HIV prevention research in developing countries -- a case study of 10 research centers in Eastern and Southern Africa.
AIDS Care
; 24(10): 1277-89, 2012.
Artículo
en Inglés
| MEDLINE | ID: mdl-22452384
14.
Quantifying rates of HIV-1 flow between risk groups and geographic locations in Kenya: A country-wide phylogenetic study.
Virus Evol
; 8(1): veac016, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35356640
15.
Acceptability and tolerability of repeated intramuscular electroporation of Multi-antigenic HIV (HIVMAG) DNA vaccine among healthy African participants in a phase 1 randomized controlled trial.
PLoS One
; 15(5): e0233151, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32469893
16.
Willingness to participate in future HIV vaccine trials among men who have sex with men and female sex workers living in Nairobi, Kenya.
PLoS One
; 15(8): e0238028, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32834018
17.
Specificity of CD8+ T-Cell Responses Following Vaccination with Conserved Regions of HIV-1 in Nairobi, Kenya.
Vaccines (Basel)
; 8(2)2020 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-32485938
18.
Reported willingness to participate in a hypothetical HIV vaccine trial and its translation to actual participation among healthy adults-Experience from Kenya.
PLoS One
; 13(11): e0206656, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30388145
19.
Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.
PLoS One
; 12(9): e0183788, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28880880
20.
Cohort Profile: IAVI's HIV epidemiology and early infection cohort studies in Africa to support vaccine discovery.
Int J Epidemiol
; 50(1): 29-30, 2021 03 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32879950